CHI3L1 and neoplasm: Together, these clinical results demonstrated for the first time that tumors from advanced lung cancer patients with poor survival was characterized by a distinct immunosuppressive TME with a high level of stromal CHI3L1+Rab37+ associated with tumor infiltrating M2 macrophages.